Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CRVSCRVS
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CORVUS PHARMACEUTICALS INC

Yes. Geode Capital Management holds 1,853,659 shares of CRVS (Corvus Pharmaceuticals), worth $27.7M, as of its Q2 2026 13F filing. It increased the position by 140,918 shares (+8.2%) from Q1 2026. Geode Capital Management has held CRVS in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$27.7M

Current Shares

1.9M

Total Value Change

+$24.7M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+8.2%
$27.7M0.0%$14.94
31
2026-Q1
Increased
1.7M
+16.3%
$25.1M0.0%$17.53
33
2025-Q4
Increased
1.5M
+1.1%
$11.3M0.0%$7.49
28
2025-Q3
Increased
1.5M
+7.0%
$10.7M0.0%$7.28
30
2025-Q2
Increased
1.4M
+130.7%
$5.4M0.0%$3.89
44
2025-Q1
Increased
590,286
+4.1%
$1.9M0.0%$3.38
27
2024-Q4
Increased
566,863
+0.7%
$3M0.0%$5.25
26
2024-Q3
Increased
563,009
+22.4%
$3M0.0%$5.15
32

Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used